Untargeted proteomic differences between clinical strains of methicillin-sensitive and methicillin-resistant

Philip Nikolic1, Poonam Mudgil1, David G Harman1

  • 1School of Medicine, Western Sydney University, Campbelltown, NSW, Australia.

Microbial Pathogenesis
|April 22, 2023
PubMed

Insights

Methicillin-sensitive and resistant Staphylococcus aureus strains show distinct protein profiles. These differences in bacterial proteins may influence antibiotic resistance and offer new targets for drug development.

Area of Science:

  • Microbiology
  • Proteomics
  • Bacterial Pathogenesis

Background:

  • Staphylococcus aureus is a significant human pathogen.
  • Increasing antibiotic resistance in S. aureus complicates infection management.
  • Understanding strain-specific differences beyond known resistance mechanisms is crucial for novel therapeutic strategies.

Purpose of the Study:

  • To compare the proteomic profiles of clinical methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) strains.
  • To identify general protein abundance differences between MSSA and MRSA.
  • To explore potential links between protein profile variations and antibiotic resistance.

Main Methods:

  • Proteomic analysis of five MSSA and five MRSA clinical strains.
  • Utilized ultra-performance liquid chromatography-mass spectrometry (UPLC-MS).
  • Protein identification performed using Progenesis QI for Proteomics and the UniProt S. aureus database.

Main Results:

  • Significant differences in protein abundance were observed between MSSA and MRSA strains.
  • Proteins involved in virulence, metabolism, and protein synthesis were differentially expressed.
  • Data is publicly available via ProteomeXchange (identifier PXD021629).

Conclusions:

  • Distinct proteomic profiles exist between antibiotic-sensitive and resistant S. aureus clinical isolates.
  • These protein differences may contribute to or be associated with methicillin resistance.
  • Further investigation into these proteomic variations could reveal new therapeutic targets for combating MRSA infections.